$SKTO +0.0011 (+6.88%) Latest News SK3 Group, Inc
Post# of 44805
![](/assets/46931549/no_avatar_available_thumb.jpg)
SK3 Group, Inc. (OTC Pink: SKTO) (PINKSHEETS: SKTO) is pleased to announce that the first bottles of its new medicinal cannabis product, T-Hydrocan(TM) RMC 40, will be available this Wednesday, April 23, 2014, from Pharmajanes.com, and soon thereafter from collectives which carry the YAK Edibles line of medical marijuana products. The "RMC" designation indicates "refined mixed cannabinoids."
T-Hydrocan(TM) RMC 40 tablets contain 40 mg. of fully activated (decarboxylated) THC, along with the attendant cannabinoids that are found in the cannabis/hemp source material. The cannabis oils have been thoroughly refined utilizing organic processing materials which have been approved for contact with food, yielding a translucent red or gold colored essential oil containing highly concentrated cannabinoids, terpenes, terpenoids, amino acids, and other refined elements of the essential oil of cannabis.
T-Hydrocan(TM) RMC 40 is packaged 8 tablets per bottle. The suggested retail price is $35.00 per bottle.
T-Hydrocan(TM) RMC 40 was developed by Berkeley Bio-Organic Research Laboratories, Inc. and is available through Pharmajanes.com and select dispensaries throughout California. The next product in the T-Hydrocan(TM) product line will be T-Hydrocan(TM) Whole Plant 25 tablets and capsules.
https://wfwsconsulting.wistia.com/medias/zr3kpio28q
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)